Related Experiment Video
Updated: Aug 15, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Endothelium and inflammation
M Piro1, G Giubilato, M Pinnelli
1Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.
Insights
Coronary heart disease (CAD) involves inflammation, with endothelial dysfunction as a key early event. Assessing endothelial vasomotion may serve as a valuable biomarker for atherosclerotic vascular disease.
Area of Science:
- Cardiovascular Medicine
- Inflammation Research
- Vascular Biology
Background:
- Coronary heart disease (CAD) pathophysiology is increasingly understood as an inflammatory process.
- Endothelial dysfunction is a critical early event in the development of atherosclerosis.
- Risk factors like dyslipidemia, hypertension, and hyperglycemia contribute to endothelial activation.
Purpose of the Study:
- To review the evolving understanding of atherosclerosis as an inflammatory disease.
- To highlight the role of endothelial dysfunction in the early stages of CAD.
- To explore the potential of endothelial vasomotion as a biomarker for atherosclerotic vascular disease.
Main Methods:
- Review of current scientific literature on atherosclerosis and endothelial function.
- Analysis of the molecular mechanisms linking endothelial dysfunction to vascular inflammation and thrombosis.
- Synthesis of emerging data on endothelial vasomotion as a diagnostic marker.
Main Results:
- Atherosclerosis is characterized by vascular inflammation initiated by endothelial dysfunction.
- Activated endothelium promotes leukocyte adhesion, vascular inflammation, and thrombosis.
- Endothelial dysfunction involves increased expression of adhesion molecules, production of inflammatory mediators, and pro-thrombotic factors.
Conclusions:
- Endothelial dysfunction is a central mechanism in the development of atherosclerotic vascular disease.
- The activated endothelium contributes to vascular inflammation and thrombosis through various pathways.
- Endothelial vasomotion assessment shows promise as a biomarker for detecting and monitoring atherosclerotic disease.
Abstract:
During the past decade, our understanding of the pathophysiology of coronary heart disease (CAD) has undergone a remarkable evolution. To date atherosclerosis is considered an inflammatory disease, whose the endothelial dysfunction represents an early key event. When the arterial endothelium encounters certain bacterial products or risk factors, such as dyslipidemia, vasoconstrictor hormones involved in hypertension, the products of glycoxidation associated with hyperglycemia, or proinflammatory cytokines derived from excess adipose tissue, these cells increase the expression of adhesion molecules that promote the sticking of blood leukocytes to the inner surface of the arterial wall. Once in the arterial intima these cells communicate with endothelium and smooth muscle cells, under the influence of mediators of inflammation and immunity, such as the cytokines and complements components, prostanoids and leukotrienes. Thus, the activated endothelium promotes the development of the atherosclerotic disease process, i.e., vascular inflammation and thrombosis by producing vasoconstrictor substances, by inducing the expression of adhesive receptors for leukocytes and platelets, the production of tissue factor and endothelin, and by increasing the production of the plasminogen activator inhibitor-1. Emerging data support the concept that assessment of endothelial vasomotion may be a useful biomarker for atherosclerotic vascular disease.
Related Concept Videos
Inflammation
Overview of the Vascular System
Inflammation: Introduction
Acute Inflammation II: Cellular Phase
Acute Inflammation III: Local and Systemic Effects
Structure of Blood Vessels

